002A-00 woolly mammoth
View More 
Colossal Biosciences – the company behind an ambitious, Jurassic Park-style effort to revive extinct bird and mammal species such as the thylacine, dodo and woolly mammoth – said it had raised another $200 million through a Series C funding round led by TWG Global.
The investment values Colossal at $10.2 billion after raising $435 million in total funding. The company said it would use the new capital “to continue to advance its genetic engineering technologies while pioneering new revolutionary software, wetware and hardware solutions, which have applications beyond de-extinction including species preservation and human healthcare.”
Colossal CEO and co-founder Ben Lamm said investors “have been bullish in their desire to help us scale as quickly and efficiently as possible. This funding will grow our team, support new technology development, expand our de-extinction species list, while continuing to allow us to carry forth our mission to make extinction a thing of the past.”
To Learn More Click Here
